ArticleBone marrow transplantation2021

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing.

Jae-Sook Ahn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.